Skip to main content
. 2022 Jun 27;36(7):659–679. doi: 10.1007/s40263-022-00932-2

Fig. 5.

Fig. 5

Monitoring for clozapine-induced cardiotoxicity [90, 131133]. Less or more frequent monitoring may be appropriate depending on the clinical situation and local guidelines. aSymptoms may include chest pain, edema, shortness of breath, and other signs associated with heart failure. If signs or symptoms develop, or cardio markers are elevated, increase the frequency of troponin and C-reactive protein tests until normalized